Funder: Pfizer Inc.

Due Dates: April 28, 2026: Submission Deadline (full application submission deadline; applications submitted after this date will not be reviewed; deadline is 23:59 Eastern Standard Time)

Funding Amounts: Up to $50,000 per project; total RFP budget is $250,000; project duration up to 12 months.

Summary: Supports research on real-world clinical, safety, microbiological, and economic outcomes of Aztreonam-Avibactam (ATM-AVI) for gram-negative infections in adults.